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Abstract
Acinetobacter baumannii is an emerging bacterial pathogen that causes nosocomial pneumonia and other infections.
Although it is recognized as an increasing threat to immunocompromised patients, the mechanism of host defense against
A. baumannii infection remains poorly understood. In this study, we examined the potential role of macrophages in host
defense against A. baumannii infection using in vitro macrophage culture and the mouse model of intranasal (i.n.) infection.
Large numbers of A. baumannii were taken up by alveolar macrophages in vivo as early as 4 h after i.n. inoculation. By 24 h,
the infection induced significant recruitment and activation (enhanced expression of CD80, CD86 and MHC-II) of
macrophages into bronchoalveolar spaces. In vitro cell culture studies showed that A. baumannii were phagocytosed by
J774A.1 (J774) macrophage-like cells within 10 minutes of co-incubation, and this uptake was microfilament- and
microtubule-dependent. Moreover, the viability of phagocytosed bacteria dropped significantly between 24 and 48 h after
co-incubation. Infection of J774 cells by A. baumannii resulted in the production of large amounts of proinflammatory
cytokines and chemokines, and moderate amounts of nitric oxide (NO). Prior treatment of J774 cells with NO inhibitors
significantly suppressed their bactericidal efficacy (P,0.05). Most importantly, in vivo depletion of alveolar macrophages
significantly enhanced the susceptibility of mice to i.n. A. baumannii challenge (P,0.01). These results indicate that
macrophages may play an important role in early host defense against A. baumannii infection through the efficient
phagocytosis and killing of A. baumannii to limit initial pathogen replication and the secretion of proinflammatory cytokines
and chemokines for the rapid recruitment of other innate immune cells such as neutrophils.
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Introduction
Acinetobacter baumannii is a ubiquitous, Gram-negative, opportu-
nistic pathogen that frequently induces nosocomial and commu-
nity-acquired pneumonia, skin and urinary tract infections, and
bacteremia [1–3], especially in immunocompromised individuals
[4]. Moreover, A. baumannii infections are becoming increasingly
difficult to treat due to the rapid development of resistance to
antibiotics [3,5]. Thus, A. baumannii infection can lead to significant
morbidity and mortality, with an overall 30-day mortality rate as
high as 49% for respiratory tract infections [6].
Despite its clinical importance, relatively little is known about
the innate host defense mechanisms against respiratory A.
baumannii infection. Recent studies by several groups, including
us, have shown that CD14, TLR-4 signaling, neutrophils,
NADPH phagocyte oxidase, and complement are crucial in the
control of local bacterial multiplication and subsequent extrapul-
monary dissemination [7–12]. On the other hand, TLR-2, NOS2
or IL-17 play little to no role [9,11,13].
Similar to the neutrophil, the macrophage is another important
phagocyte that is generally involved in host defense against
pathogen invasion. Alveolar macrophages (AMs) are the first line
of innate immune cells in the distal respiratory tract that are
capable of detecting and eliminating invading pathogens as well as
initiating the early host immune response. In this regard, AMs play
a critical role in host resistance against both intracellular and
extracellular bacterial pathogens [14–17], and are capable of
clearing a low inoculum of bacteria without the recruitment of
neutrophils [18]. However, to the best of our knowledge, there are
no studies that have systemically evaluated the macrophage
function during respiratory A. baumannii infection. In this study, we
examined the relative contribution of macrophages in the host
defense against A. baumannii infection using in vitro J774A.1 (J774)
macrophage cell culture and the mouse model of intranasal (i.n.) A.
baumannii infection. Our data suggest that macrophages may play
an important role in the early host defense against respiratory A.
baumannii infection.
Results and Discussion
Alveolar macrophage responses to intranasal A.
baumannii infection in mice
Since AMs are the front line of innate immune cells that combat
respiratory pathogens, we first determined the kinetics of AM
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e40019recruitment in C57BL/6 mice in response to an i.n. A. baumannii
infection. As shown in Fig. 1A, the total number of bronchoal-
veolar lavage (BAL) cells was moderately reduced at 2 hours post
infection (hpi) with approximately 10
8 colony-forming units (CFU)
A. baumannii, but was significantly increased by 24 hpi (P,0.01).
Macrophages comprised nearly all of the cells recovered from the
BAL fluid at 0 and 2 (100% and 98.7%, respectively) hpi. By
4 hpi, some neutrophils (25%) were present in the BAL and by
24 hpi, approximately 90% of the all BAL cells were neutrophils
(Fig. 1B). Despite the decrease in the proportion of macrophages
in the BAL fluid at 24 hpi, the absolute number of macrophages
actually increased significantly at this time point (P,0.01)(Fig. 1B).
Flow cytometric analysis of macrophage surface markers
showed no substantial changes in the activation markers CD40,
CD80, CD86 or MHC-II (I-A
b) at 2 or 4 hpi, but the expression of
CD80, CD86 and MHC-II was significantly increased at 24 hpi
(P,0.001)(Fig. 2). More importantly, many AMs at 4 hpi
contained high numbers of bacteria within their cytoplasm
(Fig. 3) while only a few bacteria were visible in the cytoplasm
of small numbers of neutrophils at this time point. These results
suggest that A. baumannii induce moderate activation and
recruitment of AMs into the lungs, and AMs are capable of
taking up A. baumannii cells shortly after i.n. infection of the mice.
In vitro uptake of A. baumannii by macrophages
To further characterize the interaction between A. baumannii and
macrophages, we examined the in vitro uptake of A. baumannii by
the murine macrophage cell line J774A.1 (J774 cells). A. baumannii
were incubated with J774 cells at a multiplicity of infection (MOI)
dose of 100. After 4 h incubation, 1.3660.13610
6 CFU bacteria
were detected inside J774 macrophages, representing about 3% of
the total initial inoculated bacteria. Moreover, the uptake of A.
Figure 1. Brochoalveolar macrophage responses to intranasal inoculation with A. baumannii. Groups of C57BL/6 mice (n=5 per group)
were i.n. inoculated with 10
8 CFU of freshly cultured A. baumannii. The mice were euthanized at the indicated times and the lungs were lavaged. The
total number of bronchoalveolar lavage (BAL) fluid cells was determined by a hemocytometer (A) and the differential count of macrophages (B, left)
and neutrophils (B, right) was determined by examining Hema3-stained cytospin slides. Data are representative of three independent experiments
with similar results and presented as mean 6 SD. **P,0.01 vs 0 h.
doi:10.1371/journal.pone.0040019.g001
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were internalized by the macrophages as early as 10 min after
inoculation, and the level of uptake continued to increase until the
end of the treatment (4 h)(Fig. 4). These results support the finding
of the above in vivo study and showed that macrophages can
rapidly and efficiently phagocytose A. baumannii in vitro in a time-
dependent fashion without the presence of antibody or comple-
ment opsonization.
Figure 2. Activation of CD11c+ alveolar macrophages following intranasal inoculation of A. baumannii. Groups of C57BL/6 mice were i.n.
inoculated with 10
8 CFU of freshly cultured A. baumannii. The mice were euthanized at the indicated times and the lungs were lavaged. The
expression of CD40, CD80, CD86 and MHCII by CD11c+ macrophages, measured as mean fluorescence intensity (MFI), was determined by FACS
analysis. Data are compiled from two independent experiments with similar results, and are presented as mean 6 SD (n=6 per time point).
***P,0.001 vs 0 h.
doi:10.1371/journal.pone.0040019.g002
Figure 3. In vivo phagocytosis of A. baumannii by alveolar
macrophages. C57BL/6 mice were i.n. inoculated with 10
8 CFU of
freshly cultured A. baumannii and euthanized 4 h later. The lungs were
lavaged and the lavage fluid was used for the preparation of cytospin
slides. BAL cells were stained with Hema3 and observed under a light
microscope. A representative photo of at least 10 samples is presented.
Arrows: alveolar macrophages containing large numbers of A.
baumannii. Arrowheads: neutrophils containing small numbers of A.
baumannii.
doi:10.1371/journal.pone.0040019.g003
Figure 4. Time dependent in vitro phagocytosis of A. baumannii
by J774 macrophages. J774 (5610
5 cells) cells were infected with
100 MOI of A. baumannii in 500 ml DMEM complete medium for the
indicated time. The cells were then treated with 100 mg/ml gentamicin
for 2 h and lysed as described in Materials and Methods. The released
ingested bacteria were enumerated by serial dilution on BHI agar
supplemented with 50 mg/ml streptomycin. The phagocytosis index
was calculated by using the following formula: [bacteria recovered
(CFU/ml)/bacteria inoculated (CFU/ml)]6100=% phagocytosed. Data
are compiled from three separate experiments and are expressed as
means of individual experiments 6 SD where applicable (30, 60 and
120 min).
doi:10.1371/journal.pone.0040019.g004
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J774 macrophages
To further understand the interaction between A. baumannii and
macrophages, we determined the levels of interleukin (IL)-1b, IL-
6, macrophage inflammatory protein (MIP)-2, tumor necrosis
factor (TNF)-a, IL-10 and nitric oxide (NO) in the culture
supernatant of J774 cells at 0 (no infection), 4, 24 or 48 h after
inoculation with 100 MOI of A. baumannii (Fig. 5). This panel of
cytokines and chemokines was selected for study because they have
previously been implicated in the immunopathogenesis of A.
baumannii infection in mouse models and in human cell culture
studies [7,9,11,13,19–21]. At 4 h, the levels of IL-6 and TNF-
a increased .100-fold (P,0.05) and .400-fold (P,0.001),
respectively, as compared to 0 h. Similarly, the level of MIP-2
also increased about 100-fold (P,0.001) although there was no
significant change in the levels of IL-1b or IL-10. At 24 and 48 h,
levels of MIP-2 and TNF-a were maintained at the levels observed
at 4 h while IL-6 and IL-1b concentrations increased significantly
and peaked at 24 h (P,0.01)(Fig. 5). The IL-10 level did not
change significantly in the first 24 h but then increased
significantly at 48 h, in comparison with uninfected cultures
(P,0.001). Although NO was undetectable (,2.6 nmol) at 0 or
4 h, significant amounts of NO were detected in infected culture
supernatants collected 24 and 48 hpi (P,0.001)(Fig. 5).
Our previous studies have shown that respiratory A. baumannii
infection in mice induces local production of moderate amounts of
inflammatory cytokines TNF-a, IL-1, IL-6, MIP-2, and anti-
inflammatory cytokine IL-10 [7]. However, the cellular sources of
these cytokines were not identified. Here we show that macro-
phages, after infection with A. baumannii, produced high levels of
IL-6, TNF-a and MIP-2 as early as 4 hpi. MIP-2 and TNF-a levels
peaked at 4 hpi, and IL-6 and IL-1b levels peaked at 24 hpi,
respectively (Fig. 5). These results suggest that macrophages
participate in the early inflammatory responses and host defense
against A. baumannii infection. In this regard, it is interesting to note
that the production of MIP-2 (a key neutrophil chemotactic
chemokine in mice) by macrophages rose rapidly and reached
a high level 4 h after infection. It is possible that macrophage-
derived MIP-2 may contribute significantly to the early neutrophil
recruitment following A. baumannii infection in vivo but this can only
be definitively concluded after conducting studies using MIP-2
knockout mice.
Mechanisms of A. baumannii entry into macrophages
It has been well established that entry of bacteria into
macrophages depends on different receptors, and requires certain
cell skeleton changes. To elucidate the potential molecular
mechanisms involved in the uptake of A. baumannii by macro-
phages, we examined the effect of cytochalasin D, nocodazole, and
tunicamycin on the uptake of A. baumannii by J774 cells.
Cytochalasin D interferes with the microfilament system rear-
rangement of eukaryotic cells by blocking actin polymerization,
which is necessary for macrophage phagocytosis [22–23].
Nocodazole specifically disrupts the cellular microtubulin system,
which is essential for receptor-mediated endocytosis of small
particles [23–24] while tunicamycin interferes with surface
receptor N-glycosylation [20]. As shown in Fig. 6, pretreatment
of J774 macrophages with cytochalasin D inhibited the uptake of
A. baumannii in a dose-dependent manner, with .80% of inhibition
at a concentration as low as 0.1 mg/ml. The uptake of A. baumannii
by J774 macrophages was also inhibited by nocodazole and
tunicamycin (Fig. 6). These results indicate that the phagocytosis of
A. baumannii by J774 macrophages requires intact/functional
microfilament and microtubulin systems.
Killing of phagocytosed A. baumannii by J774
macrophages
The killing of phagocytosed pathogens is an important function
of macrophages, and is also a major host defense strategy in
combating extracellular bacterial infections. We therefore deter-
mined the ability of J774 macrophages to kill phagocytosed A.
baumannii. J774 cells were infected for 2 h with 100 MOI of A.
baumannii, and the cells were lysed after 24 or 48 h to recover
viable A. baumannii. As shown in Fig. 7, more than 80% of J774
phagocytosed A. baumannii cells were killed at 24 h post-phagocy-
tosis, and 99% were killed by 48 h. However, .90% of A.
baumannii phagocytosed by mouse neutrophils were killed after
only one hour of incubation (Fig. 7). Thus, it would appear that in
comparison to neutrophils, macrophages are less efficient in killing
phagocytosed A. baumannii.
Potential mechanism of macrophage-mediated killing of
A. baumannii
Macrophages employ a variety of mediators such as NO,
reactive oxygen species and phagolysosome-associated enzymes to
kill phagocytosed pathogens [18,25]. Since NO is one of the major
effector molecules in bactericidal action of macrophages [26] and
NO production is significantly increased in A. baumannii-infected
macrophages (Fig. 5), we examined the potential significance of
NO in macrophage killing of A. baumannii. J774 cells were treated
with NO inhibitor L-NAME or its non-functional isomer D-
NAME one hour before being infected with A. baumannii. As shown
in Fig. 8, both L-NAME and D-NAME treated macrophages
killed substantial numbers of internalized bacteria at 24 hpi.
However, the inhibition of A. baumannii in L-NAME-treated
J774 cells was ,20% greater than in the D-NAME-treated cells
(P,0.01), indicating a role for NO in macrophage-mediated
killing of A. baumannii. However, after 48 h incubation, both L-
NAME and D-NAME treated cells showed similar level of
bacterial inhibition (data not shown). Treatment of J774 cells
with L-NMMA, another NO inhibitor, for 24 h also showed
a similar reduction in the killing of phagocytosed A. baumannii as L-
NAME (Fig. 8). These results indicate that NO plays a moderate
role in the killing of phagocytosed A. baumannii by macrophages in
the first 24 h after infection. Thus, it is likely that NO contributes
to the bactericidal function of macrophages at an early stage of
infection before sufficient numbers of neutrophils are recruited at
the site of infection. At the later stage of infection, the contribution
of NO could be largely compensated or replaced by other more
efficient mechanisms (such as neutrophil-mediated killing). These
results are in agreement with our previous in vivo work, which
showed that iNOS knockout mice are only slightly more
susceptible to i.n. A. baumannii infection than wild-type mice [9].
Since our previous studies have shown that NADPH oxidase-
deficient (gp91
phox2/2) mice that lack the production of reactive
oxygen species (ROS) are highly susceptible to A. baumannii
infection [9], we also measured ROS production by J774
macrophages in response to A. baumannii infection, and its potential
contribution in the subsequent killing of A. baumannii. In contrast to
NO responses, we found that J774 cells, either at rest or infected
with A. baumannii, produced virtually no ROS although its
production increased substantially after 1 h phorbol 12-myristate
13-acetate (PMA) stimulation (Fig. 9). Although our in vitro study
excluded any significant contribution of ROS in macrophage-
mediated killing of A. baumannii, it remains possible that in vivo, the
macrophages may be activated by a matrix of cytokines and
inflammatory mediators and produce ROS to eliminate phagocy-
tosed A. baumannii. Further studies of the activation of macro-
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infection are necessary to resolve this question.
Bactericidal effect of NO on A. baumannii
The above results (Fig. 8) suggest that NO only partially
contributes to the killing of A. baumannii by J774 macrophages, and
A. baumannii is only moderately susceptible to the bactericidal effect
of NO. We next tested the susceptibility of A. baumannii to NO
directly in bacterial culture broth supplemented with an NO
donor, DETA/NO which induced NO production in the culture
broth (Fig. 10A). The viability of A. baumannii in the broth
supplemented with 1 or 5 mM NO donor was reduced by
approximately 1 log after 2 h, and by approximately 2 logs and
3 logs respectively after 6 h incubation (P,0.001)(Fig. 10B). By
24 h after DETA/NO addition, A. baumannii viability is similar at
all concentrations of DETA/NO (Fig. 10C) while viability is still
significantly reduced in the more susceptible E. coli bacteria
(P,0.01) at the 5 mM dose of DETA/NO (Fig. 10D). In addition,
we also compared the susceptibility of five different clinical isolates
of A. baumannii with strain ATCC 17961 to 5 mM DETA/NO and
found that all of these isolates had similar susceptibilities (Fig. 10E).
In contrast, more than 3 log reduction in A. baumannii was
observed after only 1 h incubation in the presence of 5 mM H2O2
(data not shown). These data confirm that A. baumannii is only
moderately susceptible to the bactericidal effect of NO.
Alveolar macrophages function in host resistance to
intranasal A. baumannii infection in mice
Results of the above in vitro experiments (Figs. 4, 5, 6, 7, 8, 9, 10)
suggest that macrophages may play some role in the early stage of
host defense against A. baumannii infection. We next examined the
role of AMs in host defense against i.n. A. baumannii infection in
AM-depleted mice. Groups of C57BL/6 mice were intranasally
treated with clodronate-liposome to deplete AMs (AM-depleted
Figure 5. Proinflammatory cytokine and chemokine production by A. baumannii-infected J774 macrophages. J774 cells were infected
with A. baumannii (MOI=100) for 2 h. The cells were then rinsed with HBSS and treated for 2 h with complete medium containing 100 mg/ml
gentamicin to kill extracellular bacteria. Cell culture supernatants were collected at 0 (no infection), 4, 24 and 48 h after bacterial inoculation. The
concentrations of indicated cytokines/chemokines were measured by Luminex and the NO level was assessed using Griess reagent. Data are
presented as mean 6 SD (n=3). **P,0.01, ***P,0.001 vs 0 h.
doi:10.1371/journal.pone.0040019.g005
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control (control mice) [15,27]. Twenty-four hours later, the mice
were i.n. inoculated with 1610
8 CFU A. baumannii, and bacterial
burdens in the lung, BAL fluid and spleen were determined at 4,
24, 48 and 72 h after infection (Fig. 11). The bacterial burdens in
the lung and BAL fluid were not significantly different between
AM-depleted and control mice at 4 hpi, but at 24 hpi significantly
higher numbers of bacteria were recovered in the BAL fluid of
AM-depleted mice (P,0.01). At 48 and 72 hpi, significantly more
bacteria were detected in both the lung and BAL fluid of AM-
depleted mice (P,0.01). The overall bacterial burdens in the
spleens of infected mice were relatively low, and there was no
significant difference between AM-depleted and control mice at
any time point. We also determined a panel of 6 proinflammatory
cytokine and chemokine levels in the BAL fluid of these mice at
4 hpi and found that the AM-depleted mice had significantly
lower levels of IL-6, MIP-2 and TNF-a (p,0.001) than control
mice (Fig. 12), whereas the levels of IL-1b, KC, and RANTES
were similar between the two groups of mice.
These results indicated that AMs do play a subtle, but important
role in early host resistance against i.n. A. baumannii infection.
However, in comparison with previous studies with neutrophil-
depleted mice [7,11], the contribution of AMs to overall host
defense in this model is relatively insignificant. Depletion of
neutrophils converted a self-limiting infection into a lethal
infection, whereas there was no death observed in AM-depleted
mice in this study. In addition, the bacterial burdens in the lungs of
neutropenic mice are about 100 times higher than control IgG-
treated mice [7], while the difference between AM-depleted and
control mice was only about 10 times (Fig. 11). Several factors may
contribute to the different resistance observed between AM-
depleted and neutropenic mice during i.n. A. baumannii infection.
Firstly, AMs may be inherently less efficient in killing A. baumannii
since our in vitro experiments showed that it required 24 h for AMs
to kill 80–90% of phagocytosed A. baumannii while neutrophils can
kill a similar percentage of bacteria in one hour (Fig. 7). Secondly,
clodronate-liposome administration can only deplete about 80% of
AMs and the depletion is largely restricted to terminal bronchioles
and alveolar space [28]. On the other hand, RB6-8C5 monoclonal
antibody treatment depletes .90% of pulmonary neutrophils and
.95% of circulating neutrophils for at least 2 days [7]. Finally,
although administration of clodronate-liposome depleted AMs, it
Figure 6. Effect of biochemical inhibitors on the uptake of A.
baumannii by J774 cells. J774 cells were pretreated for 1 h with
various concentrations of the indicated biochemical inhibitors. The cells
were then infected with 100 MOI of A. baumannii for 2 h, followed by
a 2 h incubation with gentamicin to kill extracellular bacteria. The
numbers of phagocytosed bacteria were determined as detailed in
Figure 4. Data are presented as mean 6 SD (n=3). **P,0.01, vs 0 h.
doi:10.1371/journal.pone.0040019.g006
Figure 7. Survival of ingested A. baumannii in J774 cells and
neutrophils. J774 cells and neutrophils were infected with 100 or
10 MOI of A. baumannii, respectively, and extracellular bacteria were
killed by gentamycin as detailed in Figure 4. The cells were lysed at
indicated times (hours) after infection to determine viable bacterial
counts by quantitative bacteriology. Data are expressed as the
percentage of the ingested bacteria that were killed by J774 cells or
neutrophils at indicated time and presented as mean 6 SD (n=3 for
J774 macrophages and n=9 for neutrophils). The neutrophil data are
compiled from three independent experiments.
doi:10.1371/journal.pone.0040019.g007
Figure 8. Effect of iNOS inhibitors on the killing of A. baumannii
by macrophages. J774 cells were treated with 2 mM iNOS inhibitors
(L-NAME or L-NMMA) or controls (D-NAME or media) before being
infected with A. baumannii as described in Figure 4. Cells were lysed
after 24 h and the numbers of viable A. baumannii were determined by
plating on BHI-S plates. The inhibition of bacterial growth is calculated
by the formula: % inhibition=100 – [(viable bacteria at 24 h/viable
bacteria at 4 h)6100]. Data are presented as mean 6 SD (n=3) and are
representative of three independent experiments. **P, 0.01 vs
respective controls.
doi:10.1371/journal.pone.0040019.g008
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neutrophils, presumably in response to the cellular debris and
soluble molecules released from the lysed macrophages. These
neutrophils may partially compensate for the loss of AMs in
control of bacterial replication. Nevertheless, the early phagocy-
tosis and killing of bacteria by AMs may be important to contain
the initial bacterial burden until neutrophils can be recruited to kill
A. baumannii more efficiently and clear the infection.
In summary, the interaction between A. baumannii and the host
innate immune system is likely to govern the extent of bacterial
proliferation and local host inflammatory response following
pulmonary bacterial infection. In this regard, AMs are the
predominant phagocytes in the lung, and reside in the distal
airway and alveolar spaces. They form the front line of phagocytes
that initiate early innate immune responses against pulmonary
pathogen invasion, as schematically summarized (Fig. 13). In this
regard, macrophages express a wide array of pathogen pattern
recognition molecules (such as TLRs, surface scavenger receptors
and mannose receptors) to recognize and phagocytose bacterial
and non-bacterial pathogens, and initiate inflammatory responses
[29–30]. In this study, we used both an in vitro macrophage cell line
and an AM depletion mouse model to examine the function of
macrophages in the phagocytosis, killing, and regulation of
inflammatory responses during A. baumannii infection. Our results
showed, for the first time, that although macrophages play
a relatively minor role in the overall host defense against A.
baumannii infection, they play an important role in the initial stage
of host defense against respiratory A. baumannii infection partially
through an NO-dependent mechanism. Although at this stage it is
not clear whether macrophage dysfunction directly contributes to
any nosocomial or community-acquired A. baumannii infection,
many studies have revealed that some risk factors (such as cigarette
smoke or alcohol abuse) are positively associated with nosocomial
and community-acquired infections including A. baumannii [25,31–
33]. Smoke or alcohol consumption is also correlated with
impaired immune responses including AM dysfunction in phago-
cytosis, killing of bacteria, and cytokine secretion [25,34–37].
Further study of these risk factors and the correlated macrophage
dysfunction may provide more detailed information about
nosocomial and community-acquired A. baumannii infection.
Materials and Methods
Mice and cell lines
Eight- to twelve-week-old C57BL/6 mice were purchased from
Charles River Laboratories (St Constant, QC, Canada). They
were housed under specific-pathogen-free conditions in the
Animal Resources, Institute for Biological Sciences, National
Research Council Canada (Ottawa) and given free access to sterile
water and certified mouse chow. The animals were maintained
and used in accordance with the recommendations of the
Canadian Council on Animal Care Guide to the Care and Use
of Experimental Animals. This study and all animal care/use
protocols were approved (ID # 2006.20, 2009.12 and 2010.18) by
the Institute for Biological Sciences (National Research Council
Canada) Animal Care Committee.
The mouse macrophage-like cell line J774A.1 (ATCC TIB-67,
J774) was obtained from American Type Culture Collection
(Manassas, VA). J774 is a well-established mouse macrophage-like
cell line that has been commonly used in functional studies of
phagocytosis and killing because of its similarity to normal
macrophages [23]. All cells were maintained in Dulbecco’s
Modified Eagle Medium (DMEM) (Sigma-Aldrich, St. Louis,
MO) supplemented with 10% heat-inactivated fetal bovine serum
and 10 mM HEPES (Invitrogen, Burlington, ON) at 37uC with
5% CO2.
Intranasal infection of mice with A. baumannii
For each in vivo experiment, fresh inocula were prepared as
previously described [7]. Anesthetized mice were inoculated i.n.
with ,10
8 CFU A. baumannii in 50 ml saline. This dosage induces
a self-limiting bronchopneumonia in C57BL/6 mice without
mortality [7]. Actual inoculum concentrations were determined
by plating 10-fold serial dilutions on brain-heart infusion agar
supplemented with 50 mg/ml streptomycin (BHI-S). Mice were
euthanized at the indicated times and the lungs were lavaged five
times with a total of 5.0 ml PBS supplemented with 3 mM EDTA
as previously described [7,38]. The total number of BAL cells was
determined with a hemacytometer and differential cell counts were
determined by examining 200 cells on cytospin slides (Cytospin 3,
Shandon, Pittsburgh, PA) stained with Hema-3H (Fisher Scientific,
Kalamazoo, MI)[7].
Figure 9. ROS production by J774 macrophages. Cultured J770 cells were incubated with CM-H2DFDA and stimulated with PMA (A) for 30 min
or A. baumannii (B) for 2 h. ROS production was measured by FACS analysis of the change in fluorescence intensity upon the treatment. Green line:
control treatment; red line: PMA (A) or A. baumannii (B) treatment, respectively.
doi:10.1371/journal.pone.0040019.g009
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The percentage and activation of AMs in the BAL fluid were
determined by FACS analysis as described previously [39]. Briefly,
BAL cell samples were washed in PBS containing 1% BSA. The
cells were incubated with unlabeled anti-CD16/CD32 (clone
2.4G2) monoclonal antibodies (BD Biosciences) for 15 min to
block non-specific Fc receptor binding. Aliquots containing
,10
6 cells were stained with antibody cocktails containing
appropriate fluorochrome-conjugated mAb for 30 min at 4uC.
The anti-CD11c (clone HL3) mAb was used as a marker for AMs
and the activation of CD11c+ AMs was further analyzed using
anti-CD80 (clone 16-10A1), anti-CD86 (clone GL1), anti-CD40
(clone 3/23), and anti-MHCII (AF6-120.1) antibodies. After
staining, the cells were washed twice with the above PBS/BSA
solution, fixed with 200 ml of 1% paraformaldehyde (Polysciences
Inc., Warrington, PA), and stored in the dark at 4uC until ready
for quantitative analysis. The data were acquired using a FACS
Canto flow cytometer (BD Biosciences, San Jose, CA) and
analyzed using FlowJo software (Tree Star, Inc., Ashland, OR).
In vitro infection of J774 cells with A. baumannii
Freshly grown A. baumannii (ATCC 17961) were prepared from
a frozen stock as previously described [7]. The bacterial cells were
then concentrated in Tryptic Soy Broth (TSB) with 40% glycerol
and aliquots were stored at 280
uC for use in infection studies. One
ml aliquots of J774 (5610
5 cells/ml) cells were seeded into 24-well
tissue culture plates (Becton Dickinson, Mississauga ON). After
overnight culture, confluent cells were infected with 100 MOI of
A. baumannii in 500 ml complete medium per well for 2 h as
described by Choi et al.[40]. The cells were then washed 3x with
Figure 10. The effect of the NO-donor DETA/NO on viability of A. baumannii grown in broth culture. 10
5 CFU freshly grown bacteria were
treated with 0, 1.0 or 5.0 mM of DETA/NO for 2, 6 and 24 h. (A) The nitrite concentration in the culture broth at 2 and 6 h after DETA/NO addition in
two of the three experiments. (B) The numbers of viable bacteria at 2 and 6 h were determined by quantitative bacteriology. The data are
representative of 3 independent experiments. ***P,0.001 vs 0 mM. (C and D) Comparative susceptibility of 10
5 CFU A. baumannii (C) or E. coli (D)
upon exposure to 0, 1.0 or 5.0 mM of DETA/NO for 2, 6 and 24 h. ***P,0.001 vs 0 mM. (E) Comparative susceptibility of exposure of various A.
baumannii clinical isolates and the ATCC 17961 strain to 5 mM DETA/NO for 6 h.
doi:10.1371/journal.pone.0040019.g010
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containing 100 mg/ml gentamicin to kill extracellular bacteria.
Phagocytosis assay
J774 cells that were incubated with A. baumannii for the
indicated times were lysed with 0.1% Triton X-100 after a 2-h
incubation with gentamicin. The number of viable bacteria
recovered was determined by culturing serial dilutions of the
lysates on BHI-S plates. The phagocytosis index was calculated by
using the following formula: [bacteria recovered (CFU/ml)/
bacteria inoculated (CFU/ml)]6100=% phagocytosed. The same
phagocytosis assay was used to test time-dependent phagocytosis
and the potential mechanism of A. baumannii phagocytosis. In these
experiments, J774 cells were either co-incubated with A. baumannii
for a series of time periods ranging from 10 min to 4 h as
indicated, or were treated with cytochalasin D (0.1 to 1 mg/ml),
nocodazole (0.1 to 5 mg/ml), or tunicamycin (2 to 5 mg/ml)(all
from Sigma-Aldrich) for 30 (cytochalasin D) or 60 (nocodazole and
tunicamycin) min before the addition of A. baumannii. The total
number of viable A. baumannii recovered was similarly determined
and used for the calculation of phagocytosis index. Pilot
experiments confirmed that all the chemical reagents showed no
direct effect on the replication of A. baumannii or the viability of
J774 cells in the dose and time used (data not shown).
Bactericidal assay
To determine the killing of A. baumannii by J774 cells, the above
phagocytosis assay was modified by further incubation of the
infected monolayers for up to 48 h. Intracellular viable bacteria at
4, 24 and 48 h were determined as described above. For the 24
and 48 h cultures, cells were maintained in DMEM supplemented
with only 10 mg/ml gentamicin to minimize the potential
intracellular accumulation of antibiotics and subsequent killing
of intracellular bacteria. Pilot experiments confirmed that this
concentration of gentamicin completely killed the extracellular
bacteria after overnight incubation (data not shown).
To study the role of nitric oxide (NO) in the killing of
phagocytosed A. baumannii by macrophages, J774 cells were treated
withL-NMMA(1 mM),orL-NAME(2 mM),orD-NAME(2 mM)
1 h before infection [41]. Cells were then infected with 100 MOI A.
baumannii as described above. NOS inhibitors and controls were
added again after infection. Intracellular viable bacteria were
determined at 4, 24 and 48 h after the addition of A. baumannii.
Production of cytokines, chemokines and NO by A.
baumannii-stimulated macrophages
In some experiments, culture supernatants were harvested at 0,
4, 24 and 48 h after A. baumannii infection. Supernatants from
Figure 11. In vivo depletion of alveolar macrophages enhances
the host susceptibility to i.n. A. baumannii challenge. Groups of
C57BL/6 mice were i.n treated with either clodronate-liposomes to
deplete alveolar macrophages or PBS-liposomes as treatment controls.
Twenty-four hours later, all mice were i.n infected with 1610
8 CFU of
freshly cultured A. baumannii. Five mice from each group were
euthanized at 4, 24, 48 and 72 h after the infection. The bacterial
burdens in the lung, BAL fluid, and spleen were determined by
quantitative bacterial culture. Dashed line indicates lower limit of
detection (1.3 log10). Data are presented as mean 6 SD (n=5).
**P,0.01.
doi:10.1371/journal.pone.0040019.g011
Figure 12. Depletion of alveolar macrophages alters early
proinflammatory cytokine and chemokine responses to i.n. A.
baumannii challenge. Groups of C57BL/6 mice were i.n. treated with
either clodronate-liposomes to deplete alveolar macrophages or PBS-
liposomes as treatment controls. Twenty-four hours later, all mice were
i.n. infected with 1610
8 CFU freshly cultured A. baumannii. The mice
were euthanized at 4 h after the infection and their lungs were lavaged.
The concentrations of indicated cytokines/chemokines in the BAL fluid
were measured using the mouse panel of Fluorokine MAP Multiplex kits
on a Luminex 100 IS system. The detection limit for all cytokines and
chemokines is ,10 pg/ml. Data are presented as means 6 SD (n=5).
***P,0.01 vs. PBS-treated mice.
doi:10.1371/journal.pone.0040019.g012
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and served as baseline controls. The supernatants were filter
sterilized and stored at 220uC until assay. The level of selected
cytokines and chemokines were determined by using the mouse
panel of Fluorokine MAP Multiplex Kits (R & D Systems, Inc.
Minneapolis, MN) on a LuminexH 100 IS system (Luminex,
Austin, TX). The analysis was done in duplicate, and cytokine/
chemokines concentrations were calculated against the standards
using BeadviewH software (ver 1.03, Upstate) as described
previously [7]. The NO2
2 levels in the culture supernatants were
determined by Griess assay [42]. Briefly, 100 ml culture superna-
tants were mixed with an equal volume of Griess reagent (0.5%
sulfanilamide and 0.05% N-1-naphthylethylenediamide hydro-
chloride in 2.5% acetic acid). After 30 min incubation at room
temperature, the mixture was measured spectrophotometrically at
550 nm. The NO2
2 concentration was determined from a stan-
dard curve prepared with NaNO2.
DETA/NO and bacterial viability
To test the direct bactericidal effect of NO, NO was generated
using diethylenetriamine/nitric oxide adduct (DETA/NO, Sigma-
Aldrich, St. Louis), a compound that decomposes spontaneously
with a half-life of approximately 20 h [43]. Bacteria were freshly
grown in TSB broth and then diluted in tryptic soy broth to
a concentration of approximately 10
5 CFU/ml and exposed to 0,
1 or 5 mM DETA/NO. The viable bacterial counts (CFU/ml) at
various hours after incubation at 37
uC were determined by plating
serial dilutions on BHI plates.
Figure 13. Schematic depiction of the potential role of alveolar macrophages during early host defense against intranasal A.
baumannii infection. Intranasally inoculated A. baumannii are rapidly taken up by resident alveolar macrophages (AM) shortly after infection. The
infection stimulates the synthesis and production of bactericidal molecules such as nitric oxide (NO) which kills some A. baumannii inside AMs or in
the alveolar space and partially controls the replication of A. baumannii. Some AMs containing viable A. baumannii migrate to the regional lymph
nodes and initiate extrapulmonary dissemination. The proinflammatory cytokines/chemokines (such as MIP-2 and KC) produced by AMs and other
pulmonary resident cells (such as dendritic cells and alveolar epithelial cells) in response to A. baumannii induce the recruitment of neutrophils from
peripheral circulation into bronchoalveolar spaces where they release oxidative radicals (O2
2 and H2O2) to clear the infection.
doi:10.1371/journal.pone.0040019.g013
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Alveolar macrophages were depleted by i.n. administration of
liposome encapsulated dichloromethylene diphosphonate (clodro-
nate, or CL2MDP, a gift of Roche Diagnostics GmbH,
Mannheim, Germany). Liposomes containing clodronate (clodro-
nate-liposomes) and liposomes encapsulating PBS (PBS-liposomes)
were prepared as described previously [28]. Groups of five
C57BL/6 mice were administrated with 100 ml of clodronate-
liposomes or PBS-liposomes by intranasal route. Twenty-four
hours later, the mice were inoculated i.n. with ,10
8 CFU A.
baumannii as described above. Infected mice were sacrificed at 4,
24, 48 or 72 hpi, and the lungs, BAL fluid, and spleens were
aseptically removed or collected, and used for quantitative
bacteriology [7].
Statistical analysis
Data are presented as means 6 SD for each group, unless
otherwise specified. Differences in quantitative measurements
were assessed by Student’s t test, one-way analysis of variance
(ANOVA) followed by Dunnett’s test or two-way ANOVA
followed by Bonferroni’s post-hoc multiple comparison tests, when
appropriate. Differences were considered significant when
P,0.05. All statistical analysis were performed using GraphPad
Prism 4 (Graphpad Software, La Jolla, CA, USA).
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